Dietary Patterns May Possibly Be Linked to Prostate Cancer Risk
Plant-based diets might lower risk, animal-based diets containing dairy might raise risk for prostate cancer
Prostate Cancer
PSA Levels No Different With Exposure to Antidiabetes Meds
Regardless of PSA levels triggering biopsy, no difference in prostate cancer detection at biopsy.
Prostate Cancer Treatment Regimens
Find detailed treatment options for prostate cancer, including clinical trials and anticancer agents such as docetaxel, prednisone, and sipuleucel-T.
Prostate Cancer Risk Higher Among Men With IBD
Men with ulcerative colitis may be particularly at risk for prostate cancer, according to researchers.
The Disappointing Reality of Crowdfunding Cancer Care
If crowdfunding doesn’t work, here’s how oncologists can help patients with financial toxicity.
Some Targeted Therapies May Miss the Mark
Ten different drugs continued to kill cancer cells even when their target proteins were removed.
Apalutamide Plus ADT for mCSPC Maintains Health-Related Quality of Life
In the TITAN trial, health-related quality of life did not worsen with the addition of apalutamide to ADT versus placebo for patients with metastatic castration-sensitive prostate cancer.
Many Can Avoid RT After Surgery for Localized Prostate Cancer
Progression-free survival no different at five years when radiotherapy is used only if the cancer returns.
Cabazitaxel Superior to Switching Antiandrogens for Third-Line mCRPC Treatment
In mCRPC patients previously treated with docetaxel and either abiraterone or enzalutamide, third-line therapy with cabazitaxel offered longer imaging-based progression-free survival and overall survival compared with switching patients to the other antiandrogen, the CARD study found.
Long-Term Antiandrogen Therapy With Salvage Radiation May Up Death Risk
In a secondary analysis of NRG Oncology/RTOG 9601, some patients had no survival benefit from long-term antiandrogen treatment.
Next post in Prostate Cancer
